Cell Therapy Manufacturing Market Key Highlights:
- Market Size (2024): USD 4,139 Million
- Projected Market Size (2034): USD 15,753 Million
- CAGR (2024-2034): 14.3%
Pricing Analysis:
- Price Growth
- Regional Variations
Market Historic Sales
- Total sales volume, year-over-year growth, product categories, and market share.
Revenue Estimation
- Forecasting future revenues based on historical data, market trends, and economic indicators.
Sales by Region
- Breakdown of sales performance across different geographical areas.
Revenue by Manufacturer
- Analysis of revenue contributions from different manufacturers in the market.
Cell Therapy Manufacturing Market Definition
The cell therapy manufacturing market is growing notably and is expected to grow substantially in the coming years. The market involves the industries that produce cell therapy medicinal products. It includes the process of isolating, modifying, growing, formulating, quality testing, and storing the cells for clinical and commercial use. Recent research and development activities and investments are fuelling market growth as the demand for innovative technologies is growing with a growing number of patients around the world.
A lack of understanding of cell therapy manufacturing's workings can disturb the supply chain, leading to critical players failing to meet consumer demand. Cell therapy manufacturing is complicated due to biological complexity and requires specialized equipment and highly trained personnel, limiting the market's growth. However, rising investments by both the private and public sectors, large players in the biotechnology sectors, and the growing use of new technologies in treatment models are driving growth in the market. They are expected to help the cell therapy manufacutring market expand in the coming years. The market is currently dominated by the United States, followed by the United Kingdom and China.
Cell Therapy Manufacturing Market Segmentation:
By Source
By Indication
- HIV
- Autoimmune Disorders
- Immune Deficiencies
- Cancer
- Neurological Disorders
By Manufacturing Purpose
- Clinical
- Commercial
- Pre-clinical
By Route of Administration
- Topical
- Injectable
- Infusion
- Implantable Bio-Scaffold
By Cell Type
- Hematopoietic (Blood-Forming) Stem Cells (HSC)
- Skeletal Muscle Stem Cells
- Mesenchymal Stem Cells
- Lymphocytes
- Dendritic Cells
- Pancreatic Islet Cells
- CAR-T Cells
By End User
- Hospital Settings
- Intensive Outpatient Treatment Centers
- Academic and Research Institutes
- Specialty Clinics
Cell Therapy Manufacturing Market Companies:
- Merck KGaA
- Avantor, Inc.
- Cell Therapies Pty Ltd
- Thermo Fisher Scientific
- Charles River Laboratories
- Catalent, Inc
- Bio-Techne
- Cytiva
- Lonza
- The Discovery Labs
- BIOCENTRIC
- FUJIFILM Diosynth Biotechnologies
- Novartis AG
- Bristol-Myers Squibb Company
- Gilead Sciences, Inc.
- WuXi AppTec.
- OXGENE
- Pharmaron
- Aldevron
- FLODESIGN SONICS
- Exothera
For any questions about this dataset or to discuss customization options, please write to us at sales@statifacts.com
